Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Work (Reading, Mass.)|January 21, 2014
Hand care begins with prevention in elementary schoolsG M LucasAnnals of Internal Medicine|July 27, 1999
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactionsG M Lucas, R E Chaisson, R D MooreAIDS (London, England)|September 8, 2001
Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenzG M Lucas, R E Chaisson, R D MooreJournal of Acquired Immune Deficiency Syndromes (1999)|July 21, 2001
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infectionG M Lucas, L W Cheever, R E Chaisson, et al.HIV Medicine|August 30, 2008
The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART eraM D Burkey, L E Wilson, R D Moore, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 1998
Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomesG M Lucas, N Lechtzin, D W Puryear, et al.HIV Medicine|September 13, 2013
Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individualsG M Lucas, A Cozzi-Lepri, C M Wyatt, et al.HIV Medicine|February 26, 2015
Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialA C Achhra, A Mocroft, M J Ross, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2017
Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney DonorsA D Muzaale, K N Althoff, C J Sperati, et al.Pageof 1